Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-002052

President and CEO sold 3,922 shares at $3.27 ($12,825)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-04 Sale : show line 1 in the form −3,922 $3.27 $12,825 608,605 D
Open-market sales · 3,922 sh · avg $3.27 · $12,825
Loading xslF345X03/doc4.xml…